24/7
Buzz
Startups
VC
AI
Innovation
Opinions
Events
Promising Startups 2024
BiblioTech
Boarding Pass
Corporate
Appointments
CTalk
Tech Gateways
2025 VC survey
@Finance
Ctech Testimonials
Shopping
Projects
Spotlight
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Patent
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
Innovation
OPINIONS
EVENTS
SHOPPING
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
10:51
Women, work, and menopause: Navigating income, expenses, and career transitions
10:31
Harvard professor files $2M claim against insolvent tech founder Moshe Yanai amid $120M debt crisis
10:12
Carbon is the next cyber: Why Israel must enter the global carbon market now
09:50
ZIM faces pivotal vote as company weighs at least three acquisition offers
More stories
Buzz
Most popular
Daily
Weekly
1
“Other countries have air-defense systems, but Israel’s are better”: Arrow 3 lands in Germany as Israel pursues new mega deals
2
Nice puts Actimize up for sale at a $1.5-2 billion price tag
3
Johny Srouji weighs leaving Apple, raising stakes for the Israeli executive who built its silicon program
4
Zafran raises $60 million and doubles valuation as it chooses independence over takeover offers
5
Israeli drone startup Heven hits $1 billion valuation in $100 million round led by IonQ
More news
Patent
2 stories about Patent
Teva’s Stock Drops After Approval of Copaxone Competitors
08.10.17
|
Lilach Baumer
A day after Mylan announced FDA approval for its generic versions of Copaxone, drug companies Synthon and Alvogen announce European approval for their 40 mg/ml generic versions of Teva's blockbuster drug
Your First Investor Meeting, a Survival Guide
27.09.17
|
Zachi Zach
Your first meeting with a potential investor is critical because you probably won’t get another chance. Do your homework
Previous Articles